MK2 INHIBITORS
The present invention relates to compounds of general Formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used in the treatment of immune, autoimmune, inflammatory diseases, cardiovascular diseases, infectious diseases, bone resorption disorders, neurodegenerative disease...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | OUBRIE ARTHUR BARF TJEERD ANDRIES ZWART EDUARD WILLEM SCHULTZ-FADERMRECHT CARSTEN DE WILDE SANDER MARTIJN HOOGENBOOM NIELS KAPTEIN ALLARD |
| description | The present invention relates to compounds of general Formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used in the treatment of immune, autoimmune, inflammatory diseases, cardiovascular diseases, infectious diseases, bone resorption disorders, neurodegenerative diseases or proliferative diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2014288109A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2014288109A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2014288109A13</originalsourceid><addsrcrecordid>eNrjZODz9TZS8PTz8HTyDPEPCuZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGhiZGFhaGBpaOhsbEqQIANMcd1A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MK2 INHIBITORS</title><source>esp@cenet</source><creator>OUBRIE ARTHUR ; BARF TJEERD ANDRIES ; ZWART EDUARD WILLEM ; SCHULTZ-FADERMRECHT CARSTEN ; DE WILDE SANDER MARTIJN ; HOOGENBOOM NIELS ; KAPTEIN ALLARD</creator><creatorcontrib>OUBRIE ARTHUR ; BARF TJEERD ANDRIES ; ZWART EDUARD WILLEM ; SCHULTZ-FADERMRECHT CARSTEN ; DE WILDE SANDER MARTIJN ; HOOGENBOOM NIELS ; KAPTEIN ALLARD</creatorcontrib><description>The present invention relates to compounds of general Formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used in the treatment of immune, autoimmune, inflammatory diseases, cardiovascular diseases, infectious diseases, bone resorption disorders, neurodegenerative diseases or proliferative diseases.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140925&DB=EPODOC&CC=US&NR=2014288109A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140925&DB=EPODOC&CC=US&NR=2014288109A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OUBRIE ARTHUR</creatorcontrib><creatorcontrib>BARF TJEERD ANDRIES</creatorcontrib><creatorcontrib>ZWART EDUARD WILLEM</creatorcontrib><creatorcontrib>SCHULTZ-FADERMRECHT CARSTEN</creatorcontrib><creatorcontrib>DE WILDE SANDER MARTIJN</creatorcontrib><creatorcontrib>HOOGENBOOM NIELS</creatorcontrib><creatorcontrib>KAPTEIN ALLARD</creatorcontrib><title>MK2 INHIBITORS</title><description>The present invention relates to compounds of general Formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used in the treatment of immune, autoimmune, inflammatory diseases, cardiovascular diseases, infectious diseases, bone resorption disorders, neurodegenerative diseases or proliferative diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZODz9TZS8PTz8HTyDPEPCuZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGhiZGFhaGBpaOhsbEqQIANMcd1A</recordid><startdate>20140925</startdate><enddate>20140925</enddate><creator>OUBRIE ARTHUR</creator><creator>BARF TJEERD ANDRIES</creator><creator>ZWART EDUARD WILLEM</creator><creator>SCHULTZ-FADERMRECHT CARSTEN</creator><creator>DE WILDE SANDER MARTIJN</creator><creator>HOOGENBOOM NIELS</creator><creator>KAPTEIN ALLARD</creator><scope>EVB</scope></search><sort><creationdate>20140925</creationdate><title>MK2 INHIBITORS</title><author>OUBRIE ARTHUR ; BARF TJEERD ANDRIES ; ZWART EDUARD WILLEM ; SCHULTZ-FADERMRECHT CARSTEN ; DE WILDE SANDER MARTIJN ; HOOGENBOOM NIELS ; KAPTEIN ALLARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2014288109A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>OUBRIE ARTHUR</creatorcontrib><creatorcontrib>BARF TJEERD ANDRIES</creatorcontrib><creatorcontrib>ZWART EDUARD WILLEM</creatorcontrib><creatorcontrib>SCHULTZ-FADERMRECHT CARSTEN</creatorcontrib><creatorcontrib>DE WILDE SANDER MARTIJN</creatorcontrib><creatorcontrib>HOOGENBOOM NIELS</creatorcontrib><creatorcontrib>KAPTEIN ALLARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OUBRIE ARTHUR</au><au>BARF TJEERD ANDRIES</au><au>ZWART EDUARD WILLEM</au><au>SCHULTZ-FADERMRECHT CARSTEN</au><au>DE WILDE SANDER MARTIJN</au><au>HOOGENBOOM NIELS</au><au>KAPTEIN ALLARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MK2 INHIBITORS</title><date>2014-09-25</date><risdate>2014</risdate><abstract>The present invention relates to compounds of general Formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used in the treatment of immune, autoimmune, inflammatory diseases, cardiovascular diseases, infectious diseases, bone resorption disorders, neurodegenerative diseases or proliferative diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2014288109A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | MK2 INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T09%3A26%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OUBRIE%20ARTHUR&rft.date=2014-09-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2014288109A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |